Maraviroc D6
| Product Name | Maraviroc D6 |
|---|---|
| Alternate Names | Maraviroc Stable Isotopes, Stable Isotopes of Maraviroc |
| CAT No. | CS-O-06744 |
| CAS No. | 1033699-22-7 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 519.70 g/mol |
| Mol. For. | C₂₉H₃₅D₆F₂N₅O |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Maraviroc |
| Purity | Not less than 90 % |
| Therapeutic | Antiretroviral / Anti-HIV |
| Smileys | O=C(C1CCC(F)(F)CC1)N[C@H](C2=CC=CC=C2)CCN3[C@@H]4C[C@H](N5C(C(C([2H])([2H])[2H])C([2H])([2H])[2H])=NN=C5C)C[C@H]3CC4 |
| Canonical Smiles | CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C |
| InchIKey | GSNHKUDZZFZSJB-ICIYIAOWSA-N |
| Inchl | InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1/i1D3,2D3 |
| IUPAC | 4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-[3-(1,1,1,3,3,3-hexadeuteriopropan-2-yl)-5-methyl-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Maraviroc D6 is a deuterated form of Maraviroc, which is an antiretroviral medication used to treat HIV-1 infection. Maraviroc D6 is a stable isotope-labeled compound that is primarily used for research purposes, including drug metabolism studies, pharmacokinetic analysis, and drug discovery processes.
Maraviroc D6 works by blocking the CCR5 receptor, which is a protein found on the surface of some immune cells. HIV-1 uses the CCR5 receptor to enter and infect immune cells. By inhibiting the CCR5 receptor, Maraviroc D6 prevents the virus from entering and infecting healthy immune cells, thereby reducing the amount of virus in the body.
The chemical formula of Maraviroc D6 is C29H22D6F3N4O, and its molecular weight is 506.60 g/mol. The compound has six deuterium atoms, which replace six hydrogen atoms in the molecule. The deuterium atoms make Maraviroc D6 more stable and resistant to degradation, which is important for accurate research results.
Maraviroc D6 is typically administered orally, and its dosage and duration of treatment depend on various factors, such as the patient's age, weight, and medical history. The medication may cause some side effects, such as dizziness, fatigue, nausea, and diarrhea. However, these side effects are usually mild and go away on their own.
In conclusion, Maraviroc D6 is a valuable tool for HIV research and drug development. Its stable isotope labeling and inhibitory mechanism make it an effective medication for reducing the viral load in HIV-1 patients.
Get an Instant Quote
Related Compounds
N-Formyl Maraviroc-d6 |